Physician leaders share key strategies for addressing prescription opioid crisis

Nov 08, 2017 - 10:01 AM

In an article published online today by NEJM Catalyst, AHA Chief Medical Officer Jay Bhatt, D.O., and Physician Leadership Forum Vice President Elisa Arespacochaga share tips and resources to help hospitals and clinicians screen for and treat opioid use disorders, communicate with patients about pain management alternatives and prescribe appropriately. “Every day, clinicians see firsthand the devastating effects of the opioid epidemic on patients, families and communities,” they note. “How clinicians provide care to patients who are opioid-dependent or have overdosed, how they think about and prescribe opioids, how they connect patients to treatment resources, and how well they are collaborating with other stakeholders in this work are all key to better treatment, results and recovery." The AHA last month released a toolkit offering guidance and case examples to help hospitals and health systems work with their patients, clinicians and communities to tackle the opioid epidemic.

Related News Articles

Headline
FDA issues guidance to expand non-opioid treatments for chronic pain
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
Study finds less than 40% of Medicare beneficiaries with OUD receive standard care
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
FDA announces labeling changes to opioid pain medications 
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
CMS issues CY 2026 physician fee schedule proposed rule
The Centers for Medicare & Medicaid Services July 14 released its calendar year 2026 proposed rule for the physician fee schedule. As required by…
Headline
Overdose deaths dropped an estimated 27% in 2024
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
FDA approves first-in-class non-opioid painkiller 
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…